Connection

Gerard Silvestri to Tomography, X-Ray Computed

Back to Details
This is a "connection" page, showing publications Gerard Silvestri has written about Tomography, X-Ray Computed.
Gerard Silvestri
Connection Strength
5.750
Tomography, X-Ray Computed
  1. Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 03; 159(3):1283-1287.
    View in: PubMed
    Score: 0.360
  2. Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 10; 158(4):1742-1752.
    View in: PubMed
    Score: 0.348
  3. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2015 Feb; 147(2):295-303.
    View in: PubMed
    Score: 0.241
  4. Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
    View in: PubMed
    Score: 0.233
  5. Response. Chest. 2014 Aug; 146(2):e70.
    View in: PubMed
    Score: 0.233
  6. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
    View in: PubMed
    Score: 0.226
  7. Computed tomography screening for lung cancer. Ann Intern Med. 2013 Jul 16; 159(2):155-6.
    View in: PubMed
    Score: 0.217
  8. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e211S-e250S.
    View in: PubMed
    Score: 0.214
  9. Bronchoscopy for the solitary pulmonary nodule: friend or foe? Chest. 2012 Aug; 142(2):276-277.
    View in: PubMed
    Score: 0.203
  10. Screening for lung cancer: it works, but does it really work? Ann Intern Med. 2011 Oct 18; 155(8):537-9.
    View in: PubMed
    Score: 0.191
  11. Influence of nodule detection software on radiologists' confidence in identifying pulmonary nodules with computed tomography. J Thorac Imaging. 2011 Feb; 26(1):48-53.
    View in: PubMed
    Score: 0.183
  12. Imprecision in automated volume measurements of pulmonary nodules and its effect on the level of uncertainty in volume doubling time estimation. Chest. 2009 Jun; 135(6):1580-1587.
    View in: PubMed
    Score: 0.159
  13. Pulmonary nodule volume: effects of reconstruction parameters on automated measurements--a phantom study. Radiology. 2008 May; 247(2):400-8.
    View in: PubMed
    Score: 0.151
  14. Screening for lung cancer. AJR Am J Roentgenol. 2008 Mar; 190(3):755-61.
    View in: PubMed
    Score: 0.149
  15. CT screening for lung cancer. N Engl J Med. 2007 Feb 15; 356(7):745; author reply 746-7.
    View in: PubMed
    Score: 0.139
  16. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 Nov; 175(11):1501-1505.
    View in: PubMed
    Score: 0.103
  17. State Variation in Low-Dose?Computed Tomography Scanning for Lung Cancer Screening in the United States. J Natl Cancer Inst. 2021 08 02; 113(8):1044-1052.
    View in: PubMed
    Score: 0.095
  18. Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report. Chest. 2021 11; 160(5):1959-1980.
    View in: PubMed
    Score: 0.094
  19. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2021 11; 160(5):e427-e494.
    View in: PubMed
    Score: 0.094
  20. Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers. Chest. 2021 05; 159(5):2060-2071.
    View in: PubMed
    Score: 0.090
  21. Robotic Bronchoscopy for Peripheral Pulmonary Lesions: A Multicenter Pilot and Feasibility Study (BENEFIT). Chest. 2021 02; 159(2):845-852.
    View in: PubMed
    Score: 0.089
  22. Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. JAMA Intern Med. 2019 12 01; 179(12):1710-1712.
    View in: PubMed
    Score: 0.084
  23. Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Ann Am Thorac Soc. 2019 11; 16(11):1360-1362.
    View in: PubMed
    Score: 0.084
  24. Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial. Chest. 2019 11; 156(5):965-971.
    View in: PubMed
    Score: 0.082
  25. Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement. J Natl Cancer Inst. 2019 04 01; 111(4):342-349.
    View in: PubMed
    Score: 0.080
  26. Surrogate Markers and the Association of Low-Dose CT Lung Cancer Screening With Mortality. JAMA Oncol. 2018 07 01; 4(7):1006-1008.
    View in: PubMed
    Score: 0.076
  27. Low-dose CT for lung cancer screening. Lancet Oncol. 2018 03; 19(3):e133-e134.
    View in: PubMed
    Score: 0.075
  28. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. Am J Respir Crit Care Med. 2017 09 01; 196(5):602-608.
    View in: PubMed
    Score: 0.072
  29. Underuse of Chest Radiography Versus Computed Tomography for Lung Cancer Screening. Am J Public Health. 2017 08; 107(8):1248-1250.
    View in: PubMed
    Score: 0.072
  30. Viewing All the Trees in the Forest: The Importance of Reporting Abnormal Findings on CT Scan When Screening for Lung Cancer. Chest. 2017 03; 151(3):525-526.
    View in: PubMed
    Score: 0.070
  31. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
    View in: PubMed
    Score: 0.069
  32. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
    View in: PubMed
    Score: 0.065
  33. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
    View in: PubMed
    Score: 0.064
  34. Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest. 1995 Nov; 108(5):1264-71.
    View in: PubMed
    Score: 0.064
  35. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):200-8.
    View in: PubMed
    Score: 0.062
  36. High yield of bronchoscopic transparenchymal nodule access real-time image-guided sampling in a novel model of small pulmonary nodules in canines. Chest. 2015 Mar; 147(3):700-707.
    View in: PubMed
    Score: 0.061
  37. Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
    View in: PubMed
    Score: 0.060
  38. Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
    View in: PubMed
    Score: 0.060
  39. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med. 2014 Nov 06; 371(19):1793-802.
    View in: PubMed
    Score: 0.059
  40. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013 Jul 18; 369(3):245-254.
    View in: PubMed
    Score: 0.054
  41. The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma. Chest. 1992 Dec; 102(6):1748-51.
    View in: PubMed
    Score: 0.052
  42. New testing for lung cancer screening. Oncology (Williston Park). 2012 Feb; 26(2):176-82.
    View in: PubMed
    Score: 0.049
  43. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
    View in: PubMed
    Score: 0.047
  44. The changing epidemiology of lung cancer with a focus on screening. BMJ. 2009 Aug 17; 339:b3053.
    View in: PubMed
    Score: 0.041
  45. A 79-year-old woman with a right paratracheal mass. Chest. 2009 May; 135(5):1384-1388.
    View in: PubMed
    Score: 0.040
  46. Lung cancer screening. Am J Med Sci. 2008 Jan; 335(1):46-50.
    View in: PubMed
    Score: 0.037
  47. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):178S-201S.
    View in: PubMed
    Score: 0.036
  48. A 69-year-old with lung mass and mediastinal lymphadenopathy on chest computed tomography. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):908-11.
    View in: PubMed
    Score: 0.036
  49. One from column A: choosing between CT, positron emission tomography, endoscopic ultrasound with fine-needle aspiration, transbronchial needle aspiration, thoracoscopy, mediastinoscopy, and mediastinotomy for staging lung cancer. Chest. 2003 Feb; 123(2):333-5.
    View in: PubMed
    Score: 0.026
  50. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest. 2003 Jan; 123(1 Suppl):147S-156S.
    View in: PubMed
    Score: 0.026
  51. Factors Associated With Lung Cancer Screening Adherence Among Patients With Negative Baseline CT Results in a Community Health Care Setting. J Am Coll Radiol. 2022 02; 19(2 Pt A):232-239.
    View in: PubMed
    Score: 0.024
  52. Diagnosis and staging of lung cancer. Clin Chest Med. 2000 Mar; 21(1):95-106, viii-ix.
    View in: PubMed
    Score: 0.021
  53. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
    View in: PubMed
    Score: 0.019
  54. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2018 04; 153(4):954-985.
    View in: PubMed
    Score: 0.019
  55. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982.
    View in: PubMed
    Score: 0.017
  56. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
    View in: PubMed
    Score: 0.017
  57. Pulmonary Lung Cancer Subspecialty Training. J Bronchology Interv Pulmonol. 2015 Oct; 22(4):281-5.
    View in: PubMed
    Score: 0.016
  58. The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Am J Respir Crit Care Med. 1995 Jul; 152(1):225-30.
    View in: PubMed
    Score: 0.016
  59. Bronchoscopic transparenchymal nodule access (BTPNA): first in human trial of a novel procedure for sampling solitary pulmonary nodules. Thorax. 2015 Apr; 70(4):326-32.
    View in: PubMed
    Score: 0.015
  60. Screening and early detection efforts in lung cancer. Cancer. 2015 May 01; 121(9):1347-56.
    View in: PubMed
    Score: 0.015
  61. Selection criteria for lung-cancer screening. N Engl J Med. 2013 Feb 21; 368(8):728-36.
    View in: PubMed
    Score: 0.013
  62. Mediastinal lymphadenopathy in patients undergoing cardiac transplant evaluation. Chest. 2011 Jun; 139(6):1451-1457.
    View in: PubMed
    Score: 0.011
  63. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):69S-77S.
    View in: PubMed
    Score: 0.009
  64. Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. Ann Thorac Surg. 2004 May; 77(5):1763-8.
    View in: PubMed
    Score: 0.007
  65. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003 Dec; 126(6):1943-51.
    View in: PubMed
    Score: 0.007
  66. Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung. Ann Thorac Surg. 2001 Dec; 72(6):1861-7.
    View in: PubMed
    Score: 0.006
  67. MELAS point mutation with unusual clinical presentation. Neuromuscul Disord. 1993 May; 3(3):191-3.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.